Advertisement

Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis

  • Krishna Latha Thammineni
  • Gaurav K. Thakur
  • Navneet Kaur
  • Basu Dev BanerjeeEmail author
Article
  • 3 Downloads

Abstract

Metastasis accounts for the majority of cancer-associated mortality and renders the targeted therapy fruitless in the patients of breast cancer. Matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF-C) are thought to be involved in tumor progression and metastasis. The aim of this study was to investigate the expression of MMP-9 and VEGF-C at both mRNA and protein levels in breast cancer and to correlate with lymph node metastasis and other clinicopathological characteristics. Biopsy specimens (N = 100) of breast cancer & benign breast disease (N = 100) were investigated for the mRNA expression of MMP-9 and VEGF-C by Real-time PCR and Protein expression by Western blot. Elevated levels of MMP-9 (p < 0.001) and VEGF-C (p < 0.001) expression were detected in breast cancer with corresponding to benign breast disease. Additionally, we found significantly increased levels of MMP-9 and VEGF-C in node-positive group with respect to node-negative group. Moreover, the levels of MMP-9 were significantly increased in larger tumor size (T3/T4) (p < 0.05) as compared to smaller size (T1/T2), which suggests that MMP-9 plays an important role in the progression of breast cancer. VEGF-C expression was associated with the TNM stage of tumor (p < 0.05). Further, a significant positive correlation was established between the mRNA levels of these two genes (p < 0.001). However, we could not obtain any significant correlation between expression of these genes with other clinicopathological parameters like tumor grade, age, menopausal status, and receptor status like ER, PR, and Her2. This study suggests that the high expression of MMP-9 and VEGF-C could act as markers for the tumor presence in breast cancer. In addition, this study recommends that expression of MMP-9 and VEGF-C was significantly associated with lymph node status and may provide valuable diagnosis of lymph node metastasis in breast cancer patients. Further, MMP-9 expression was associated with the tumor size and VEGF-C expression was correlated with the staging of the tumor, although no association was observed with other clinicopathological variables.

Keywords

Breast cancer Metastasis Lymph node metastasis Angiogenesis Matrix metalloproteinase-9 (MMP-9) Vascular endothelial growth factor-C (VEGF-C) 

Notes

Acknowledgements

The authors have not received any grants. We would like to thank University Grants Commission for providing Senior Research Fellowship to one of the author. We are also thankful to Dr. Ankur (Department of Pathology, UCMS and GTB Hospital) for providing histopathology reports of the patients, Dr. Pravin Deshmukh for editing the manuscript, and Mr. Ranjeet Kumar for technical support. Last but not least, we are extremely thankful to all those patients who provided the samples and time for this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

nformed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefGoogle Scholar
  2. 2.
    Eger A, Mikulits W (2005) Models of epithelial–mesenchymal transition. Drug Discov Today 2:57–63Google Scholar
  3. 3.
    Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161–174CrossRefGoogle Scholar
  4. 4.
    Giannelli G, Fransvea E, Marinosci F, Bergamini C, Daniele A, Colucci S, Paradiso A, Quaranta M, Antonaci S (2002) Gelatinase levels in male and female breast cancer. Biochem Biophys Res Comm 292:161–166CrossRefGoogle Scholar
  5. 5.
    Campbell NE, Kellenberger L, Greenaway J, Moorehead RA, Linnerth-Petrik NM, Petrik J (2010) Extracellular matrix proteins and tumor angiogenesis. J Oncol.  https://doi.org/10.1155/2010/586905 Google Scholar
  6. 6.
    Zhang ZQ, Han YZ, Nian Q, Chen G, Cui SQ, Wang XY (2015) Tumor invasiveness, not lymphangiogenesis, is correlated with lymph node metastasis and unfavourable prognosis in young breast cancer patients (≤ 35 years). PLoS ONE 10:e0144376CrossRefGoogle Scholar
  7. 7.
    Jia L, Du Y, Li T, Lv Y, Wang Y, Zhang Y, Zhou X, Liu W (2015) Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions. Oncol Lett 10:667–674CrossRefGoogle Scholar
  8. 8.
    Wang L, Li HG, Wen JM, Peng TS, Zeng H, Wang LY (2014) Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features. Tumori 100:321–327CrossRefGoogle Scholar
  9. 9.
    Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96:541–545CrossRefGoogle Scholar
  10. 10.
    Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG (2007) Prognostic significance of vascular endothelial cell growth factors-A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092–1100CrossRefGoogle Scholar
  11. 11.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 − ∆∆CT method. Methods 25:402–408CrossRefGoogle Scholar
  12. 12.
    Asthana S, Chauhan S, Labani S (2014) Breast and cervical cancer risk in India: an update. Indian J Public Health 58:5–10CrossRefGoogle Scholar
  13. 13.
    Mukherjee D, Zhao J (2013) The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res 3:46–57Google Scholar
  14. 14.
    Singh R, Bhatt ML, Singh SP, Kumar V, Goel MM, Mishra DP, Srivastava K, Kumar R (2016) Expression levels of tetraspanin KAI1/CD82 in breast cancers in North Indian Females. Asian Pac J Cancer Prev 17:3431–3436CrossRefGoogle Scholar
  15. 15.
    Farina AR, Mackay AR (2014) Gelatinase B/MMP-9 in tumour pathogenesis and progression. Cancers 6:240–296CrossRefGoogle Scholar
  16. 16.
    Kabashima A, Maehara Y, Kakeji Y et al (2000) Clinicopathological features and over expression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 6:3581–3584Google Scholar
  17. 17.
    Quaranta M, Daniele A, Coviello M et al (2007) MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res 27:3593–3600Google Scholar
  18. 18.
    Wu QW, Yang QM, Huang YF, She HQ, Liang J, Yang QL et al (2014) Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer. PloS ONE 9:e97804CrossRefGoogle Scholar
  19. 19.
    Abdel-Dayem HM, Ibraheim AT (2017) Expression of D2-40 in benign and malignant breast lesions and study the correlation between lymphovascular density and other prognostic factors of breast cancer. Arch Can Res 5:1CrossRefGoogle Scholar
  20. 20.
    Mylona E, Nakopoulou L, Magkou C, Nomikos A (2007) The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma. Histopathology 50:338–347CrossRefGoogle Scholar
  21. 21.
    Illemann M, Bird N, Majeed A et al (2006) MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 4:293–302CrossRefGoogle Scholar
  22. 22.
    McDaniel JM, Varley KE, Gertz J et al (2017) Genomic regulation of invasion by STAT3 in triple negative breast cancer. Oncotarget 8:8226–8238CrossRefGoogle Scholar
  23. 23.
    Mahmood NA, Fakhoury RM, Yaseen NY, Moustafa ME (2015) Matrix metalloproteinases MMP2 and MMP9 expression in stages II–III breast cancer in Iraqi women. J Med Biol Sci Res 1(3):30–37Google Scholar
  24. 24.
    Tang D, Piao Y, Zhao S, Mu X, Li S, Ma W, Song Y, Wang J, Zhao W, Zhang Q (2014) Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Med Oncol 31(7):26.  https://doi.org/10.1007/s12032-014-0026-4 CrossRefGoogle Scholar
  25. 25.
    Yurdanur S, Guzin G, Yildirim A (2011) Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast. Pathol Res Pract 207:747–753CrossRefGoogle Scholar
  26. 26.
    Li CI, Daling JR, Porter PL, Malone KE (2009) Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contra lateral breast cancer. Cancer Res 69:6865–6870CrossRefGoogle Scholar
  27. 27.
    Liang B, Li Y (2014) Prognostic significance of VEGF-C expression in patients with breast cancer: a metaanalysis. Iran J Public Health V43N2:128–135Google Scholar
  28. 28.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S et al (2003) Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol 16:309–314CrossRefGoogle Scholar
  29. 29.
    Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB (2000) The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6:4278–4286Google Scholar
  30. 30.
    Yang W, Klos K, Yang Y, Smith TL, Shi D, Yu D (2002) ErbB2 over expression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer 94:2855–2861CrossRefGoogle Scholar
  31. 31.
    Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66:159–164CrossRefGoogle Scholar
  32. 32.
    Kasangian AA, Gherardi G, Biagioli E, Torri V, Moretti A, Bernardin E et al (2017) The prognostic role of tumor size in early breast cancer in the era of molecular biology. PLoS ONE 12(12):e0189127.  https://doi.org/10.1371/journal.pone.0189127 CrossRefGoogle Scholar
  33. 33.
    Edge SB, Byrd DR, Compton CC et al (2010) Breast. In: AJCC cancer staging manual, 7th edn. Springer, New York. pp 347–376Google Scholar
  34. 34.
    Garg M, Nagpal N, Sidhu DS, Singh A (2016) Effect of lump size and nodal status on prognosis in invasive breast cancer. experience from rural india. J Clin Diagn Res 10(6):08–11Google Scholar
  35. 35.
    Zhao M, Hu HG, Huang J et al (2013) Expression and correlation of twist and gelatinases in breast cancer. Exp Ther Med 6:97–100CrossRefGoogle Scholar
  36. 36.
    Kwatra A, Aggarwal D, Gupta R, Chaturvedi AK et al (2015) Correlation of various histopathologic prognostic factors with Nottingham prognostic index and microvessel density in invasive breast carcinoma: a study of 100 cases. Indian J Cancer 52:110–113CrossRefGoogle Scholar
  37. 37.
    Abbasa NF, Shabanaa MEl-A, Habibb FM, Solimanb AA (2017) Histopathological and immunohistochemical study of matrix metalloproteinase-2 and matrix metalloproteinase-9 in breast Carcinoma. J Arab Soc Med Res 12:6–12Google Scholar
  38. 38.
    Yavuz S, Paydas S, Disel U (2005) VEGF-C expression in breast cancer. Clin Importance 22(4):368–380Google Scholar
  39. 39.
    Iqbal BM, Buch A (2016) Hormone receptor (ER, PR, HER2/neu) status and proliferation index marker (Ki-67) in breast cancers: their onco-pathological correlation, shortcomings and future trends. Med J DY Patil Univ 9:674–679CrossRefGoogle Scholar
  40. 40.
    Jinga DC, Blidaru A, Szegli G (2006) MMP9 and MMP2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlation with prognostic factors. J Cell Mol Med 10:499–510CrossRefGoogle Scholar
  41. 41.
    Brito LGustavoO, Schiavon VF, Jurandyr Moreira de Andrade, Daniel Guimara˜es Tiezzi, Fernanda Maris Peria, Heitor Ricardo Cosiski Marana Expression of Hypoxia-inducible factor 1-a and Vascular endothelial growth factor-C in locally advanced breast cancer patients Clinics 2011;66(8):1313–1319Google Scholar
  42. 42.
    Hao L, Zhang C, Qiu Y, Wang L, Luo Y, Jin M et al (2007) Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253:34–42CrossRefGoogle Scholar
  43. 43.
    Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490CrossRefGoogle Scholar
  44. 44.
    Bergers G (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744CrossRefGoogle Scholar
  45. 45.
    Yousef EM, Tahir MR, Pierre YS, Gaboury LA (2014) MMP-9 expression varies according to molecular subtypes of breast cancer. BMC Cancer 14:609CrossRefGoogle Scholar
  46. 46.
    Song J, Su H, Zhou YY, Guo LL (2013) Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis Asian Pac J Cancer Prev 14(3):1615–1621CrossRefGoogle Scholar
  47. 47.
    Wang CA, Harrell J, Iwanaga R, Jedlicka P, Ford HL (2014) Vascular endothelial growth factor-C promotes breast cancer progression via a novel anti-oxidant mechanism that involves regulation of Superoxide dismutase 3. Breast Cancer Res 16:462–462CrossRefGoogle Scholar
  48. 48.
    Kesler CT, Kuo AH, Wong HK, Masuck DJ, Shah JL, Kozak KR, Held KD, Padera TP (2014) Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells. Angiogenesis 17:419–427CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Environmental Biochemistry and Molecular Biology Laboratory, Department of BiochemistryUniversity College of Medical Sciences & G.T.B. Hospital (University of Delhi)DelhiIndia
  2. 2.Department of SurgeryUniversity College of Medical Sciences & G.T.B. Hospital (University of Delhi)DelhiIndia

Personalised recommendations